Autoimmune Diseases  >>  Nulojix (belatacept)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nulojix (belatacept) / BMS
LEEP, NCT00468403: LEA29Y (Belatacept) Emory Edmonton Protocol

Completed
2
10
US, Canada
Allogeneic Pancreatic Islet Cells, Belatacept, NUJOLIX, Basiliximab, Simulect, Mycophenolate Mofetil, Cellcept, Tacrolimus, Prograf, Intraportal infusion of islet cells
National Institute of Allergy and Infectious Diseases (NIAID), Clinical Islet Transplantation Consortium
Type 1 Diabetes Mellitus
04/12
04/13
NCT00279760: Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis

Completed
1/2
210
US, Canada, Europe
Belatacept, Abatacept
Bristol-Myers Squibb
Rheumatoid Arthritis
03/02
 

Download Options